# Netlist Inc: overview

NLST · OTC · CIK 1282631 · [Technology](/sectors/technology.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/nlst.md) · [Financials](/companies/nlst/financials.md) · [Filings](/companies/nlst/filings.md) · [Insiders](/companies/nlst/insiders.md)

Latest reported revenue: [$109.8m](/filings/0001104659-26-094127.md) for Q2 FY2026, three months to 2026-06-27, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001104659-26-094127).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [40.2](/filings/0001104659-25-110494.md) | [34.3 d](/filings/0001104659-26-032152.md) | [29.0](/filings/0001104659-26-059350.md) | [41.7](/filings/0001104659-26-094127.md) | [42.2](/filings/0001104659-25-110494.md) | [75.7 d](/filings/0001104659-26-032152.md) | [105](/filings/0001104659-26-059350.md) | [110](/filings/0001104659-26-094127.md) |
| Gross margin | % | [2.8%](/filings/0001104659-25-110494.md) | [0.7% d](/filings/0001104659-26-032152.md) | [4.5%](/filings/0001104659-26-059350.md) | [3.3%](/filings/0001104659-26-094127.md) | [4.4%](/filings/0001104659-25-110494.md) | [9.1% d](/filings/0001104659-26-032152.md) | [21.3%](/filings/0001104659-26-059350.md) | [20.8%](/filings/0001104659-26-094127.md) |
| Operating margin | % | [(24.0%)](/filings/0001104659-25-110494.md) | [(38.3%) d](/filings/0001104659-26-032152.md) | [(33.7%)](/filings/0001104659-26-059350.md) | [(15.0%)](/filings/0001104659-26-094127.md) | [(16.9%)](/filings/0001104659-25-110494.md) | [(3.1%) d](/filings/0001104659-26-032152.md) | [8.2%](/filings/0001104659-26-059350.md) | [1.2%](/filings/0001104659-26-094127.md) |
| Net margin | % | [(23.4%)](/filings/0001104659-25-110494.md) | [(37.1%) d](/filings/0001104659-26-032152.md) | [(32.7%)](/filings/0001104659-26-094127.md) | [(14.6%)](/filings/0001104659-26-094127.md) | [(16.6%)](/filings/0001104659-25-110494.md) | [(3.0%) d](/filings/0001104659-26-032152.md) | [8.2%](/filings/0001104659-26-094127.md) | [1.3%](/filings/0001104659-26-094127.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001104659-25-110494.md) | not reported | [(0.03)](/filings/0001104659-26-059350.md) | [(0.02)](/filings/0001104659-26-094127.md) | [(0.02)](/filings/0001104659-25-110494.md) | not reported | [0.03](/filings/0001104659-26-059350.md) | [0.00](/filings/0001104659-26-094127.md) |
| Free cash flow | $m | [(3.5) d](/filings/0001104659-25-110494.md) | [(9.1) d](/filings/0001104659-26-032152.md) | [(10.1)](/filings/0001104659-26-059350.md) | [(7.7) d](/filings/0001104659-26-094127.md) | [(10.3) d](/filings/0001104659-25-110494.md) | [13.2 d](/filings/0001104659-26-032152.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-01) | FY2022 (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2025-12-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [142](/filings/0001558370-24-001626.md) | [162](/filings/0001558370-24-001626.md) | [69.2](/filings/0001558370-25-004010.md) | [147](/filings/0001104659-26-032152.md) | [189](/filings/0001104659-26-032152.md) |
| Gross margin | % | [34.3%](/filings/0001558370-24-001626.md) | [7.4%](/filings/0001558370-24-001626.md) | [3.5%](/filings/0001558370-25-004010.md) | [2.0%](/filings/0001104659-26-032152.md) | [6.1%](/filings/0001104659-26-032152.md) |
| Operating margin | % | [8.0%](/filings/0001558370-24-001626.md) | [(20.7%)](/filings/0001558370-24-001626.md) | [(89.2%)](/filings/0001558370-25-004010.md) | [(37.5%)](/filings/0001104659-26-032152.md) | [(13.5%)](/filings/0001104659-26-032152.md) |
| Net margin | % | [3.4%](/filings/0001558370-24-001626.md) | [(20.6%)](/filings/0001558370-24-001626.md) | [(87.3%)](/filings/0001558370-25-004010.md) | [(36.6%)](/filings/0001104659-26-032152.md) | [(13.2%)](/filings/0001104659-26-032152.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001558370-24-001626.md) | [(0.14)](/filings/0001558370-24-001626.md) | [(0.25)](/filings/0001558370-25-004010.md) | [(0.21)](/filings/0001104659-26-032152.md) | [(0.09)](/filings/0001104659-26-032152.md) |
| Free cash flow | $m | [5.5](/filings/0001558370-24-001626.md) | [(15.5)](/filings/0001558370-24-001626.md) | not reported | [(34.7)](/filings/0001104659-26-032152.md) | [(14.8)](/filings/0001104659-26-032152.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nlst/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [KINGSWOOD WEALTH ADVISORS, LLC](/funds/1987855.md) | 2026-06-30 | $137.4k | 44,600 |  | New +44,600 |
| [NORTHLAND SECURITIES, INC.](/funds/1006938.md) | 2026-06-30 | $81.6k | 26,500 |  | Added +15,300 |
| [COMPASS FINANCIAL MANAGEMENT LLC](/funds/2148724.md) | 2026-06-30 | $33.9k | 11,000 |  | Not compared |
| [Opus Capital Group, LLC](/funds/1330325.md) | 2026-06-30 | $60 | 19,500 |  | Unchanged |

## Recent filings

[All 666 filings](/companies/nlst/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-06 | 12:05 ET | [8-K](/filings/0001104659-26-113897.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113897 |
| 2026-09-21 | 21:00 ET | [8-K](/filings/0001104659-26-109358.md) | 5.07 Shareholder vote results | 0001104659-26-109358 |
| 2026-08-11 | 21:00 ET | [10-Q](/filings/0001104659-26-094127.md) | Quarterly report, period 2026-06-27 | 0001104659-26-094127 |
| 2026-08-05 | 10:04 ET | [8-K](/filings/0001104659-26-090641.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-090641 |
| 2026-07-31 | 20:30 ET | [DEF 14A](/filings/0001104659-26-089249.md) | Proxy statement, period 2026-09-18 | 0001104659-26-089249 |
| 2026-07-30 | 11:32 ET | [8-K](/filings/0001104659-26-088464.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-088464 |
| 2026-07-02 | 20:37 ET | [8-K](/filings/0001104659-26-080376.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-080376 |
| 2026-05-12 | 20:00 ET | [10-Q](/filings/0001104659-26-059350.md) | Quarterly report, period 2026-03-28 | 0001104659-26-059350 |
| 2026-05-12 | 12:00 ET | [8-K](/filings/0001104659-26-059024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059024 |
| 2026-03-19 | 21:00 ET | [10-K](/filings/0001104659-26-032152.md) | Annual report, period 2025-12-27 | 0001104659-26-032152 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 27, 2025](/filings/0001104659-26-032152.md), filed Mar 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/5763a867-b05c-4687-8dbd-eae2e73b9c4c)

## About the filer

- CIK: 1282631
- Tickers: NLST
- Exchange: OTC
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.
